The 10 highest-paid female executives in the global pharmaceutical industry in 2019.

GEN's website recently named the top 10 female executives in the biopharmaceutical industry in 2017, based on the 2019 pay of executives disclosed by major companiesAccording to the, there are six female executives earning more than $10 million a year this year, compared with seven last year, compared with just one who made the first list in 2013 with an annual salary of more than $10 millionMoreover, this year's top female executives received about twice as much (Martine Rothblatt, $45,635,037) as the number one last year ($22,998,522)the biggest fluctuations in pay on the list were Emily MLeproust, chairman and chief executive of Twist BiosciencesShe will be paid $8,126,157 in 2019 and $524,674 in 2018, a percentage change: 1,449 percentThe other is Melissa Forbes, chairman and chief executive of Meira GTx Holdings, who will be paid $8,480,263 in 2019 and $22,998,522 in 2018, a percentage change of -63.1%In January, bio, a biotechnology innovation group, teamed up with the Center for Talent Innovation (CTI), a non-profit think tank dedicated to diversity and inclusion, to investigate a report by nearly 100 companies that measured diversity in the biotech industry: building an inclusive workforceIn the biotechnology industry, women make up 45 per cent of the workforce, 30 per cent of executives, 18 per cent of board members and 16 per cent of chief executives, according to the reportthe following list details:: United Therapeuticspositions: Chairman and CEO2019 Compensation: $45,635,037
2018 Compensation: $16,036,300
Percentage Change: 184.6%Company: MylanPosition:
CEO 2019 Compensation: 1019 $8,509,2602018 Compensation: $13,332,368
Percentage change: .38.8%Company: Agio PharmaceuticalsPositions: CEO2019 Compensation: $16,607,994
Compensation for 2018: N/A
Percentage Change: N/A
Company: AbbViePositions: Executive Vice President, Foreign Affairs, General Counsel2019 Compensation: $15,142,787
2018 Compensation: $11,383,159
Percentage Change: 24.2%Company: Editas PharmaceuticalsPositions: Chairman and CEO 2019 Compensation: $14,489,733 $6 2018 Compensation: N/A Percentage Change: N/A Company: GSK Positions: CEO 2019 Compensation: $10,644,767
2018 Compensation: $7,472,896
Percentage Change: .42.4% Company: MeiraGTx Holdings Position: Chairman and CEO 2019 compensation: $8,480,263 2018 compensation: $22,998,522
percentage change: -63.1% Company: Twist Bioscience Positions: Chairman and CEO 2019 Compensation: $8,126,157 2018 Compensation: $524,674
Change Percentage: 1 449% Company: Gilead Science Positions: Chief Commercial Officer 2019 Compensation: $8,049,386 2018 Compensation: N/A
Percentage Change: N/A
Company: Gilead Science Positions: Executive Vice President, Global Business Development Officer
2019 Compensation: $7,672,442
2018 Compensation: $100, $100 $337,826
percentage change: -25.8% .